These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31652100)

  • 1. RENAL FUNCTION AND PLASMA RENIN ACTIVITY AS POTENTIAL FACTORS CAUSING HYPERKALEMIA IN PATIENTS WITH THYROID CARCINOMA UNDERGOING THYROID HORMONE WITHDRAWAL FOR RADIOACTIVE IODINE THERAPY.
    Niri T; Horie I; Ando T; Kawahara H; Ueda M; Eto M; Sako A; Ikeuchi Y; Nakao T; Nakashima Y; Shigeno R; Ito A; Nozaki A; Haraguchi A; Natsuda S; Sagara I; Akazawa S; Kamada A; Imaizumi M; Abiru N; Usa T; Kawakami A
    Endocr Pract; 2020 Feb; 26(2):197-206. PubMed ID: 31652100
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperkalemia develops in some thyroidectomized patients undergoing thyroid hormone withdrawal in preparation for radioactive iodine ablation for thyroid carcinoma.
    Horie I; Ando T; Imaizumi M; Usa T; Kawakami A
    Endocr Pract; 2015 May; 21(5):488-94. PubMed ID: 25667379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma.
    Shakir MK; Krook LS; Schraml FV; Hays JH; Clyde PW
    Thyroid; 2008 Jul; 18(7):787-92. PubMed ID: 18631009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer.
    An JH; Song KH; Kim DL; Kim SK
    J Int Med Res; 2017 Feb; 45(1):38-50. PubMed ID: 27856930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of preparation method for radioactive iodine therapy on serum electrolytes.
    Takata N; Miyagawa M; Okada T; Kawaguchi N; Fujimoto Y; Kouchi Y; Tsuruoka S; Uwatsu K; Kido T
    Jpn J Radiol; 2023 Nov; 41(11):1247-1254. PubMed ID: 37184818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroxine treatment induces upregulation of renin-angiotensin-aldosterone system due to decreasing effective plasma volume in patients with primary myxoedema.
    Park CW; Shin YS; Ahn SJ; Kim SY; Choi EJ; Chang YS; Bang BK
    Nephrol Dial Transplant; 2001 Sep; 16(9):1799-806. PubMed ID: 11522861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of plasma renin activity in a boy with chronic hyperkalemia.
    Sauder SE; Kelch RP; Grekin RJ; Kelsch RC
    Am J Dis Child; 1987 Aug; 141(8):922-7. PubMed ID: 3307388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
    Solter D; Solter M
    Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin and aldosterone in thyroid diseases.
    Asmah BJ; Wan Nazaimoon WM; Norazmi K; Tan TT; Khalid BA
    Horm Metab Res; 1997 Nov; 29(11):580-3. PubMed ID: 9479560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal.
    Vaiano A; Claudio Traino A; Boni G; Grosso M; Lazzeri P; Colato C; Davì MV; Francia G; Lazzeri M; Mariani G; Ferdeghini M
    Nucl Med Commun; 2007 Mar; 28(3):215-23. PubMed ID: 17264781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Levothyroxine Administration and Withdrawal on the Hypothalamic-Pituitary-Thyroid Axis in Euthyroid Dogs.
    Ziglioli V; Panciera DL; Troy GC; Monroe WE; Boes KM; Refsal KR
    J Vet Intern Med; 2017 May; 31(3):705-710. PubMed ID: 28432797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren, Fosinopril, and Their Outcome on Renin-Angiotensin-Aldosterone System (RAAS) in Rats with Thyroid Dysfunction.
    Farhadi SAS; Dizaye KF
    Int J Endocrinol; 2019; 2019():5960563. PubMed ID: 31396276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible renal insufficiency attributable to thyroid hormone withdrawal in a patient with type 2 diabetes mellitus.
    Bernet VJ
    Endocr Pract; 2004; 10(4):339-44. PubMed ID: 15760778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.
    Philippou G; Koutras DA; Piperingos G; Souvatzoglou A; Moulopoulos SD
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):573-8. PubMed ID: 1424182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism.
    Price DE; O'Malley BP; Northover B; Rosenthal FD
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):67-9. PubMed ID: 1889141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
    Botella-Carretero JI; Gómez-Bueno M; Barrios V; Caballero C; García-Robles R; Sancho J; Escobar-Morreale HF
    Endocr Relat Cancer; 2004 Jun; 11(2):345-56. PubMed ID: 15163309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.